Company in focus

Indonesia's Kalbe Farma venturing into high-tech pharmacy

A worker at a Kalbe Farma factory packs medicine in Cikarang, on the outskirts of Jakarta. © Reuters

ERWIDA MAULIA, Nikkei staff writer

JAKARTA -- Indonesia's largest pharmaceutical company, Kalbe Farma, is transforming itself from a generic drug manufacturer to a high-tech pharma developer. Its 2-year-old cancer drug factory has started reaping results, and Kalbe is now accelerating research and development of stem cell therapy pro...

  • Japan still plagued by death from overwork

    TOKYO -- A suicide at Japanese advertising agency Dentsu has thrust the issue of karoshi back into the spotlight, showing how steps by the public and ...

  • Earnings preview

    Nintendo profit seen surging 160% on sale of Mariners stake

    OSAKA -- Nintendo is expected to report a 160% year-on-year increase in group net profit to around 30 billion yen ($289 million) for the April-Septemb...

  • Taiwan looking to build subs amid geopolitical shifts in Asia

    TAIPEI -- Taiwan is taking steps to develop homegrown submarines under pro-independence President Tsai Ing-wen in a bid to bolster its defense capabil...

  • AT&T makes another break in wall between media, telecoms

    NEW YORK -- Fifteen years after "the deal of the century" -- its ultimately unsuccessful merger with AOL -- Time Warner has agreed to be bought by AT&...

  • Panasonic, Tesla broaden partnership to residential storage batteries

    OSAKA -- Panasonic and Tesla Motor are broadening their battery partnership to include the manufacture and marketing of powerful, low-cost storage bat...

  • Xi Jinping setting table to raise party leaders' retirement age

    BEIJING -- China's president is pondering how he might be able to continue wielding power after his presidency ends.

  • Exclusive

    Sharp to close LED factory in Japan

    As it restructures under its new Taiwanese parent company, Sharp is preparing to shut down a factory in Hiroshima Prefecture.

  • China gobbling up Japanese government bonds

    China appears to be moving its money from U.S. Treasurys to JGBs, which could explain the yen's recent strength.